Literature DB >> 27958294

Targeted therapy: Sunitinib modulates MCL-1 and mTOR signalling.

Peter Sidaway.   

Abstract

Entities:  

Year:  2016        PMID： 27958294     DOI： 10.1038/nrclinonc.2016.208

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Dual modulation of MCL-1 and mTOR determines the response to sunitinib.

Authors:  Mohamed Elgendy; Amal Kamal Abdel-Aziz; Salvatore Lorenzo Renne; Viviana Bornaghi; Giuseppe Procopio; Maurizio Colecchia; Ravindran Kanesvaran; Chee Keong Toh; Daniela Bossi; Isabella Pallavicini; Jose Luis Perez-Gracia; Maria Dolores Lozano; Valeria Giandomenico; Ciro Mercurio; Luisa Lanfrancone; Nicola Fazio; Franco Nole; Bin Tean Teh; Giuseppe Renne; Saverio Minucci
Journal:  J Clin Invest       Date:  2016-11-28       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.